MACRO Consulting Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.24M Buy
13,619
+890
+7% +$147K 1.16% 27
2021
Q1
$2.09M Sell
12,729
-208
-2% -$33.7K 1.13% 27
2020
Q4
$2.04M Buy
12,937
+23
+0.2% +$3.39K 1.18% 27
2020
Q3
$1.77M Sell
12,914
-241
-2% -$35.7K 1.17% 29
2020
Q2
$1.86M Sell
13,155
-275
-2% -$40.1K 1.29% 20
2020
Q1
$1.98M Buy
13,430
+847
+7% +$120K 1.52% 15
2019
Q4
$1.84M Buy
12,583
+917
+8% +$124K 1.45% 27
2019
Q3
$1.51M Buy
11,666
+158
+1% +$20.8K 1.29% 37
2019
Q2
$1.61M Buy
11,508
+466
+4% +$64.5K 1.38% 35
2019
Q1
$1.55M Sell
11,042
-406
-4% -$54.4K 1.48% 29
2018
Q4
$1.48M Buy
+11,448
New +$1.6M 1.44% 28

Other funds holding JNJ

MACRO Consulting Group's JNJ Position: Q2 2021 in Review

MACRO Consulting Group increased its Johnson & Johnson (JNJ) stake by 7% in Q2 2021, buying an estimated $147K and bringing the position to 13,619 shares worth $2.24M. The position accounts for 1.16% of the portfolio, ranked #27.

MACRO Consulting Group first reported a position in JNJ in Q4 2018 and has held it in 11 quarters since. 3,325 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • MACRO Consulting Group held 13,619 shares of Johnson & Johnson worth $2.24M as of Q2 2021.
  • MACRO Consulting Group bought 890 Johnson & Johnson shares in Q2 2021, an estimated $147K.
  • Johnson & Johnson made up 1.16% of MACRO Consulting Group's portfolio in Q2 2021, its #27 holding.
  • MACRO Consulting Group first reported a position in Johnson & Johnson in Q4 2018 and has held it in 11 quarters since.
  • 3,325 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on MACRO Consulting Group's 13F filing for Q2 2021, filed 16 Aug 2021.